Natco commences phase-III clinical trial of Molnupiravir for COVID-19 treatment
First patient was dosed at Yashoda Hospitals, Hyderabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Natco Pharma
Government working to eliminate shortage of Amphotericin-B drug: Mansukh Mandaviya
He said that existing pharma companies have already started ramping up the production of the drug which is key for treating…
Lilly signs voluntary licensing agreement with Natco for baricitinib
Lilly had also signed voluntary license agreements with Cipla, Lupin, Sun Pharma, Dr Reddy’s, MSN Labs and Torrent Pharma
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment
Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients
NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…
NATCO gets tentative US FDA approval for Ibrutinib tablets
NATCO feels that it is eligible for 180 days of sole generic marketing exclusivity for all the strengths of the tablet dosage form…
Natco Pharma board okays acquiring 1 per cent in Canadian arm
Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary . The…
NATCO ventures into Pheromone based tech for Integrated Pest Management
NATCO ventures into pheromone-based tech for integrated pest management
NATCO gets US FDA nod for Everolimus tablets
They are indicated in the treatment of breast cancer and a few other types of cancers
NATCO launches Brivaracetam tablets in India
Brivaracetam is indicated towards treatment of epilepsy.